RE:Burning Questions... I have a very hard time believing that PMH who was in charge of the Phase 1 trial and knew the procedure would make the dosage and treatment mistakes that is being claimed by TLT , something is rotten. If you were PMH Would you not use the same team who done the first trial and treated patient 5 and 6.
islandphile wrote: If Ligne et al knew which dosimetry worked for Phase I patients 5 & 6 to create a CR, was the dosimetry changed in Phase II for the 8 current (or 12) patients?
If it wasn't changed, then who incorrectly administered the incorrect dose? How could this happen, was no one supervising and verifying?
If dosimetry was changed, who is responsible for this change? Was this done collabratively or did someone go rogue? Or negligence?
Does the company still have sufficient cash reserves to complete Phase II without doing another private placement?
Was Theralase sabotaged?
Some heads should roll over this.